All In Biotech

Drug Trial Radar · NCT00208039

Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates

Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates Less Than or Equal to 1250 gm Birthweight Ver 4.0

Last checked: Nov 20, 2026Latest source record: Nov 22, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

89

Actual

Start

Sep 2004

Primary completion

Not stated

Study completion Nov 2007

Sponsor

Lead sponsor
Children's Hospital of PhiladelphiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Pennsylvania; Women & Children's Hospital of Buffalo; Children's Mercy Hospital Kansas City; St. Louis Children's Hospital; UCSF Benioff Children's Hospital Oakland; Alta Bates Summit Medical Center; Long Island Jewish Medical Center
First posted
Sep 21, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 7 days, up to 10 days
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A research study that will evaluate if giving surfactant medication to premature babies weighing \< 1250 gm at birth during the second and third weeks of life will help their lungs. We are enrolling those premature babies who continue to require the breathing tube and the mechanical ventilator at days 7-10 of life.

Conditions

  • Respiratory Distress Syndrome
  • Bronchopulmonary Dysplasia

Interventions

  • InfasurfDrug

    Infasurf 3 cc/kg instilled via endotracheal tube, repeated 3 and 7 days later if infant stable and continues to meet criteria

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Surfactant therapy will decrease the mean area under the curve(of the plots of daily respiratory severity scores between days 7 and 28 of life), by 33% from historic controls.Time frame: 28 days

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.